Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.
CRRT is a medical therapy used in intensive care units to manage patients with acute kidney injury (AKI) or severe kidney dysfunction. It involves the continuous removal of waste products and excess fluids from the blood.
CRRT is used when a patient’s kidneys are unable to adequately filter waste and excess fluids from the blood, leading to dangerous levels of toxins and fluid overload.
CRRT differs from hemodialysis in that it is slower and performed continuously over 24 hours or longer periods. Hemodialysis, on the other hand, is intermittent and typically lasts for a few hours.
Yes, CRRT can be used cautiously in patients with heart failure to manage fluid overload and electrolyte imbalances, with careful monitoring of hemodynamic status.
CRRT provides gentler and more gradual fluid and solute removal, making it suitable for hemodynamically unstable patients who cannot tolerate the rapid changes associated with conventional hemodialysis.
The Accident and Emergency (A&E) department provides urgent care for acute injuries, sudden illnesses, and life-threatening conditions.
If you need emergency care, visit the A&E department or call emergency services immediately. Provide any relevant medical history and symptoms upon arrival.
Yes, you can bring a family member or friend for support. However, depending on the situation, visitor access may be restricted.
Bring identification, any current medications, and relevant medical history. This information helps the medical team provide appropriate care.
If your condition is not deemed an emergency, you may be referred to a primary care provider or scheduled for a non-urgent appointment.
The ANA Blot Test detects and identifies specific antinuclear antibodies (ANAs) in the blood, helping diagnose autoimmune diseases.
It is used to diagnose or rule out autoimmune disorders, assess disease progression, and investigate unexplained symptoms.
No fasting is required. Inform your healthcare provider about any medications or supplements you are taking.
Results are typically available within 2 to 7 days after the test.
The test can help diagnose autoimmune diseases such as lupus, scleroderma, and Sjögren’s syndrome, among others.